• S&P 500: 1,342.64
  • Change: -0.69%
$8.62 0.07 (+0.82%)
2/10/2012 4:00 PM

Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 2 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Current Price $8.62 Mkt Cap $476.16M
Open $8.50 P/E Ratio 28.40
Prev. Close $8.55 Div. (Yield) N/A (N/A)
Daily Range $8.36 - $8.62 Volume 464,198
52-Wk Range $5.42 - $9.98 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think NBIX will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

318 Outperform
52 Underperform
 

All-Star Players

93 Outperform
16 Underperform
 

Wall Street

4 Outperform
2 Underperform
 

Top NBIX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bhessel (36.52)
Submitted December 27, 2007

22 May 07As with Élan—one of our other biotechs—Neurocrine Biosciences (NBIX) have had their ups and downs. The stock was at an all-time high $70 14 months ago when the FDA somewhat surprizingly turned down their proposed anti-insomnia product,… More

5 Comments | Reply | Report this Post

zzlangerhans (99.27)
Submitted December 21, 2011

8.4 has been a fairly consistent ceiling for Neurocrine since elagolix brought the stock back into serious play a year and a half ago. Now close to the top of recent range, Neurocrine will be entering a relatively catalyst-free period as they prepare… More

Add Comment | Reply | Report this Post
NBIX VS S&P 500 (SPY)

Fools bullish on NBIX are also bullish on:

Fools bearish on NBIX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NBIX.

Recs

0
Member Avatar zCreator (71.35) Submitted: 2/9/2012 1:28:08 PM : Underperform Start Price: $8.66 NBIX Score: -0.34

Just a short term speculation.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar joryko (98.79) Submitted: 1/9/2012 3:46:09 PM : Underperform Start Price: $3.66 NBIX Score: -108.36

Good potential, especially with Elagolix, but I'm still short on NBIX just like I was over a year ago. There is simply too much uncertainty over being able to turn a profit in the next few years. Estimates range from 20 cents EPS in 2012 to losing 10 cents. 2013's outlook is fairly similar and it isn't until 2014 that it may be possible for them to turn a strong profit. However, there is much work to do before then and I will be short on this one until they prove they can turn a profit on a consistent basis. I've taken a flat out beating on this one so far, but I still can't justify it being worth this much until there is more concrete data.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar NuclearSteve (< 20) Submitted: 12/28/2011 2:27:39 PM : Outperform Start Price: $8.38 NBIX Score: -4.56

Very bullish chart pattern and bullish articles are chances for their endometriosis drug.

Report this Post Add Comment | Reply | Permalink
View All 69 Pitches »

Leaderboard

Find the members with the highest scoring picks in NBIX.

Score Leader

gsm1999

gsm1999 (< 20) Score: +257.19

The Score Leader is the player with the highest score across all their picks in NBIX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
gsm1999 < 20 3/8/2010 Outperform 5Y $2.30 +274.78% +17.59% +257.19 0 Comment
awsumrocker 65.19 3/10/2010 Outperform 3M $2.35 +266.81% +17.34% +249.47 0 Comment
stockamuteur 22.81 4/8/2010 Outperform 5Y $2.57 +235.41% +13.91% +221.50 0 Comment
Tadpole85 47.94 1/5/2010 Outperform 1Y $2.68 +221.64% +18.63% +203.01 0 Comment
borcobob 72.73 12/28/2009 Outperform 3Y $2.82 +205.67% +19.01% +186.66 0 Comment
MicroOptions 51.46 4/15/2010 Outperform 5Y $3.10 +178.06% +11.05% +167.01 0 Comment
MicroMikey 73.44 4/15/2010 Outperform 5Y $3.10 +178.06% +11.05% +167.01 0 Comment
padparadsha < 20 8/19/2009 Outperform 5Y $2.99 +188.29% +36.29% +152.00 1 Comment
royeknox 26.19 8/10/2009 Outperform 5Y $3.03 +184.49% +34.05% +150.44 0 Comment
carcanario < 20 4/23/2010 Outperform 3M $3.36 +156.93% +10.55% +146.38 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackMKMPartners 97.67 8/9/2011 Outperform NS $6.07 +42.01% +16.84% +25.17 0 Comment
TrackZacks 71.09 6/16/2010 Outperform 3M $5.37 +60.52% +20.01% +40.51 1 Comment
TrackLeerinkSwan 88.11 5/28/2008 Underperform NS $4.70 +1.28% +0.22% -1.06 5/28/2008 @ $4.76 0 Comment
TrackBearStearns 94.76 12/14/2007 Underperform NS $4.81 +79.21% -4.84% -84.05 0 Comment
TrackJefferies 84.73 12/13/2007 Underperform NS $5.20 +65.77% -5.14% -70.91 0 Comment
TrackSoros 92.67 9/30/2007 Outperform NS $10.00 -13.80% -7.74% -6.06 1 Comment
TrackLehmanBros 86.48 1/17/2007 Outperform NS $12.32 -59.25% -5.38% -53.88 2/14/2008 @ $5.02 0 Comment
TrackJimCramer 78.17 4/4/2006 Outperform 3W $63.15 -86.35% +10.21% -96.56 0 Comment

Featured Broker Partners